ADIPOQ and metabolic syndrome: Epidemiological studies showed a positive correlation between adiponectin and HDL-C, suggesting both are negative predictors of MetS as well as atherosclerotic cardiovascular diseases [10,11,12], although their relationship has not been explored for extremely high HDL-C levels where there are paradoxical increases in cardiovascular or all-cause mortalities [13,14,15,16].